Colorke (Suzhou) Biotechnology Co., Ltd Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2018

Location

Suzhou Jiangsu China

Primary Industry

Biotechnology

About

Based in Suzhou, China, and established in 2018, Colorke (Suzhou) Biotechnology Co., Ltd is a biotechnology company that focuses on molecular detection and protein detection reagents. In July 2021, the company raised series A++ funding from investors. The company has a self-develop core technology platform µ-MFP (Micro-scaled Multi-Physics coupled Force). Besides, the company has built multiple application platforms on this platform such as ultra-high sensitivity biomolecular detection platform, multiple magnetic fluorescents coded microsphere platform, and high-throughput single-cell parallel control platform.

Current Investors

IDG Capital, BrightGene Bio-Medical Technology Co., Ltd., Laurel Venture

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories

Website

www.colortechbio.com

Verticals

HealthTech

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.